TownSquare Capital’s Supernus Pharmaceuticals SUPN Stock Holding History

TownSquare Capital’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-42,449	Closed	-$1.45M	–	1356
2024 Q1	$1.45M	Buy	42,449 +12,223	+40%	+$364K	0.02%	558
2023 Q4	$875K	Buy	30,226 +6,054	+25%	+$161K	0.02%	638
2023 Q3	$666K	Buy	24,172 +6,357	+36%	+$194K	0.01%	671
2023 Q2	$536K	Buy	17,815 +2,648	+17%	+$92.7K	0.01%	747
2023 Q1	$550K	Buy	15,167 +2,726	+22%	+$105K	0.01%	649
2022 Q4	$444K	Buy	12,441 +2,193	+21%	+$76.2K	0.01%	672
2022 Q3	$347K	Buy	10,248 +1,569	+18%	+$51.1K	0.01%	552
2022 Q2	$251K	Buy	+8,679	New	+$249K	0.01%	593

Other funds holding SUPN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

TownSquare Capital's SUPN Position: Q2 2024 in Review

TownSquare Capital sold out of Supernus Pharmaceuticals (SUPN) in Q2 2024, closing a stake of 42,449 shares — an estimated $1.45M sold.

TownSquare Capital first reported a position in SUPN in Q2 2022 and held it in 8 quarters. The position peaked at $1.45M in Q1 2024. 244 funds tracked by Wall St. Rank hold SUPN as of Q2 2024.

TownSquare Capital reported no remaining Supernus Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
TownSquare Capital sold 42,449 Supernus Pharmaceuticals shares in Q2 2024, an estimated $1.45M.
TownSquare Capital first reported a position in Supernus Pharmaceuticals in Q2 2022 and held it in 8 quarters.
TownSquare Capital's Supernus Pharmaceuticals position peaked at $1.45M in Q1 2024.
244 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2024.

Based on TownSquare Capital's 13F filing for Q2 2024, filed 14 Aug 2024.